CardioSignal presented data at ESC 2024 annual meeting on atrial fibrillation detection reliability among people suspected of various heart conditions
Posted:
CardioSignal’s CEO, co-founder, and cardiologist Juuso Blomster presented the results in the session: Transforming population health through mobile technology at the European Society of Cardiology (ESC) annual meeting that was being held in London on 30 August - 2 September.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us